News

Emerita Resources Contracts SLR for Iberian Project Feasibility

Emerita Resources Contracts SLR for Iberian Project Feasibility

Emerita Resources Collaborates with SLR Consulting

Emerita Resources Corp. (TSX-V: EMO; Other OTC: EMOTF; Frankfurt: LLJA) has made a significant stride in its project development by awarding SLR Consulting Limited the contract to conduct a Pre-Feasibility Study (PFS) for the Iberian Belt West (IBW) Project. This collaboration marks a vital step toward a comprehensive evaluation of the project, with the PFS set to adhere to NI 43-101 standards, ensuring its credibility and thoroughness.

The Selection Process Behind SLR Consulting

The decision to engage SLR Consulting followed a meticulous selection process, where twenty-three firms were initially considered. After careful evaluation, five finalists were shortlisted, and SLR emerged as the most suitable partner, thanks to its experience with the IBW Project and other regional initiatives. The firm's expertise is expected to add significant value to the PFS, which is anticipated to take about six months to complete.

Insights From Leadership

David Gower, the CEO of Emerita, expressed enthusiasm about this new phase for the IBW project. He highlighted the team's progress in expanding mineral resources at IBW’s El Cura deposit. Infill drilling has been completed, allowing Emerita to upgrade Inferred Resources to the Indicated and Measured categories, paving the way for a more detailed PFS.

Key Components of the Pre-Feasibility Study

The PFS will encompass several critical elements crucial for the project's viability and will include:

  • Mine-to-mill design
  • Process plant and process flowsheet design
  • Surface infrastructure planning
  • Capital and operating cost considerations
  • Comprehensive financial analysis

Understanding Qualified Persons

In line with industry standards, the scientific and technical content of this announcement has been reviewed by qualified professionals anew. Joaquin Merino and Dan Oosterman, both certified as Qualified Persons (QP) under NI 43-101 standards, will ensure the study is conducted at a high level of integrity. Their current roles within the company, with Mr. Merino serving as President and Mr. Oosterman as Project Director, underscore their capacity to guide this project effectively.

About Emerita Resources Corp.

Emerita Resources is dedicated to the exploration and development of mineral properties, primarily focusing on Spain. With a corporate office and technical team located in Sevilla, Spain, and an administrative office in Toronto, Canada, Emerita is well-positioned to leverage its resources for strategic growth.

Connecting for More Information

For inquiries regarding Emerita's progress and initiatives, Ian Parkinson can be contacted at +1 647 910-2500. Email communications can be sent to info@emeritaresources.com, and more information can be found on the company's website at www.emeritaresources.com.

Frequently Asked Questions

What is the Iberian Belt West Project?

The Iberian Belt West Project is an initiative by Emerita Resources aimed at exploring and developing mineral resources in Spain.

Who is conducting the Pre-Feasibility Study?

SLR Consulting Limited has been contracted to complete the Pre-Feasibility Study for the IBW Project.

What is the timeline for the PFS completion?

The Pre-Feasibility Study is expected to be completed within approximately six months.

What are the key elements of the PFS?

The PFS will include mine design, process plant design, infrastructure planning, and financial analysis, among others.

Who are the Qualified Persons involved in the study?

Joaquin Merino and Dan Oosterman are the Qualified Persons responsible for overseeing the scientific and technical information in the project.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Implantica's U.S. Launch Arrives With Cash Still to Burn

Updated Category News Views 0

RefluxStop has finally stepped onto American soil, and that changes the conversation around Implantica in a very real way. FDA Premarket Approval arrived on August 20, then the first U.S. procedures were completed in early November at the University of Southern California. For a small medtech outfit, clearing that regulatory gate and getting actual patients treated are...

Continue Reading
Nellie's 50% Booking Jump Reveals a Quieter Luxury

Updated Category News Views 141

Silicon Valley’s rich are apparently tired of performing wealth for strangers, and frankly, that tracks. Nellie’s 2027 forecast says its mostly tech-money clientele is moving past the old trophy case of private jets, famous resort towns, and suites priced like small houses. The prize now is privacy, a clean schedule, and somebody competent fixing the ugly little...

Continue Reading
Hyundai’s Third SUV Crown Matters Beyond the Trophy

Updated Category News Views 0

A Three-Year Streak Is Not Just Decorative Three straight SUV-brand wins can make even a cynical car watcher pause. Hyundai has been named U.S. News & World Report’s 2027 Best SUV Brand after editors assessed vehicles from 39 brands, and that is a useful bit of outside validation in a segment where nearly everybody is throwing sheet metal, screens, and marketing dollars...

Continue Reading
NextPatient’s KLAS Marks Signal Specialty Workflow Fit

Updated Category News Views 79

A 93.3 score in healthcare software deserves a second look. Not a victory lap, not a drumroll—just a serious look at whether the product is solving an annoying, expensive operational problem for specialty practices. NextPatient’s recognition in the 2026 KLAS Emerging Solutions Top 20 Report lands in that category. The company placed in the top five for improving...

Continue Reading
illumine Targets Childcare Chain Control and Risk Gaps

Updated Category News Views 131

Expansion Gets Messy Before It Gets Impressive Childcare operators do not usually stumble because they forgot how to care for children; they stumble because the back office fractures as the network grows. One center handles fees one way, another lets enrollment leads work a different funnel, and headquarters discovers too late that its reports are arguing with each other....

Continue Reading
Rehab Equipment Growth Meets a Brutal Access Gap

Updated Category News Views 151

Rehabilitation demand is piling up faster than the equipment can reach people. That is the uncomfortable fact sitting beneath Wissen Research's forecast for a global rehabilitation equipment market rising from $19.1 billion in 2026 to $25.8 billion by 2031, a 6.2% annual growth rate. It is a respectable expansion story, not some rocket-ship fairy tale. More important, it...

Continue Reading
Sinopec's Green Fuel Push Meets a Hard Reality Check

Updated Category News Views 30

A refinery giant talking about green jet fuel at a climate summit is exactly the sort of thing that makes old energy hands squint first—and then check the asset list. Sinopec did bring more than lofty language to its Nov. 16 COP31 side event in Antalya: it brought long-range energy forecasts, named fuel-production routes, hydrogen infrastructure and operating projects....

Continue Reading
Yatsen’s November 25 Report Is the Real Beauty Test

Updated Category News Views 90

Beauty shelves can hide a lot of sins, but earnings day tends to drag them into fluorescent light. Yatsen will release unaudited third-quarter 2026 financial results before the U.S. market opens on Wednesday, November 25, then management will take questions at 7:30 a.m. Eastern Time. For anyone following NYSE:YSG, this is not a results story yet. It is a calendar marker,...

Continue Reading
Dutch Solar Homes Face a 2027 Net Metering Reset Ahead

Updated Category News Views 24

A policy switch buried in a Dutch calendar is about to rearrange millions of kitchen-table energy calculations. On 1 January 2027, the Netherlands ends net metering, or salderingsregeling, and households with solar panels will no longer offset exported power against electricity bought from the grid. That is not some abstract regulatory footnote. It changes the value of...

Continue Reading
Misunderstood Brands Bets Small Cans Can Scale Growth

Updated Category News Views 190

A tiny cocktail can is a brutal little test of whether a spirits brand has legs. Misunderstood Brands is putting four 100mL offerings on the shelf just as its Wegmans distribution expands across the East Coast, and that combination matters more than another glossy flavor announcement. The company is trying to turn products people discovered in bars and restaurants into...

Continue Reading

Top 5 Most Recently Viewed Articles

DallasNews Shareholders Urged to Support Merger Deal with Hearst

Updated Category News Views 101

Overview of the DallasNews and Hearst Merger DallasNews Corporation, the parent company of The Dallas Morning News, has proposed a significant merger with Hearst, a prominent media organization. This merger offers an enticing cash value of $15.00 per share, bringing impressive benefits to shareholders. Recently, Glass Lewis, an independent proxy advisory firm, recommended...

Continue Reading
GitLab Director Karen Blasing's Recent Stock Transactions Explained

Updated Category News Views 154

Analyzing the Recent Insider Trading at GitLab GitLab Inc. (NASDAQ:GTLB) has recently drawn the attention of investors and market analysts due to stock transactions made by its director, Karen Blasing. A recent filing with the U.S. Securities and Exchange Commission revealed that Blasing sold a considerable amount of her stock holdings, totaling more than $173,000....

Continue Reading
Avenue Living's Strategic $350 Million Debenture Offering

Updated Category News Views 202

Avenue Living Announces $350 Million Senior Unsecured Debenture Offering Avenue Living (2014) LP has recently announced a significant financial move with a $350 million offering of Series B senior unsecured debentures. This opportunity is set to be priced at par and is due by September 25, 2028, indicating a long-term strategy for the company’s financing needs. Details...

Continue Reading
Fagron Reports Strong Financial Growth with Strategic Outlook

Updated Category News Views 349

Fagron's Remarkable Financial Performance Fagron, a global leader in pharmaceutical compounding, recently showcased its impressive results for the period ending December 31, 2024. The company’s financial achievements highlight significant growth across various sectors and regions in the pharmaceutical industry, reinforcing its commitment to excellence and innovation....

Continue Reading
Dizal's Sunvozertinib Receives Breakthrough Therapy Designation

Updated Category News Views 444

Dizal's Sunvozertinib Achieves Breakthrough Therapy Designation Dizal, a biopharmaceutical company dedicated to developing innovative cancer and immunological therapies, recently announced an important milestone. The Center for Drug Evaluation of China's National Medical Products Administration has granted Breakthrough Therapy Designation for sunvozertinib, aimed at...

Continue Reading